Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products, announced today that a new study published in the journal Breastfeeding Medicine found that adding a human milk-derived cream supplement, Prolact CR®, to an exclusive human milk diet (EHMD) resuLTEd in “significantly earlier discharge” for very low birth weight infants in the neonatal intensive care unit (NICU), when compared to infants who did not receive the cream supplement.(i)
